Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
Acarix (OTCMKTS : ACIXF ) Stock
MWN-AI** Summary
MWN-AI** Analysis
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Description
Acarix AB is a Swedish medical technology company that develops innovative solutions for rapid AI-based exclusion of coronary artery disease (CAD). The CE-marked CADScor System, which has also received DeNovo approval from the FDA, is intended for patients experiencing chest pain with suspected coronary artery disease, and is designed to help reduce millions of cases of unnecessary, invasive and costly diagnostics. The CADScor System uses advanced acoustics and AI technology to non-invasively rule out CAD in less than 10 minutes, with at least 96% certainty.
Quote
| Last: | $0.0394 |
|---|---|
| Change Percent: | 9.44% |
| Open: | $0.036 |
| Close: | $0.036 |
| High: | $0.0394 |
| Low: | $0.036 |
| Volume: | 150,000 |
| Last Trade Date Time: | 04/14/2026 03:33:00 pm |
Stock Data
| Market Cap: | $37,069,565 |
|---|---|
| Float: | 1,063,743,780 |
| Insiders Ownership: | N/A |
| Institutions: | |
| Short Percent: | N/A |
| Industry: | Medical Equipment & Supplies |
| Sector: | Healthcare |
| Website: | www.acarix.com |
| Country: | SE |
| City: | Malmo |
Recent News Releases
Subscribe to Our Newsletter
**MWN-AI FAQ is based on asking OpenAI questions about Acarix (OTCMKTS: ACIXF).
